Abstract
Due to differences in the nature of extranodal lesions, diagnosis and choice of treatment tactics for diffuse lymphoma with extranodal lesions are difficult.
The aim of this work is to study the most appropriate methods for diagnosing diffuse lymphoma with extranodal lesions.
References
Alaggio, R., Amador, C., Anagnostopoulos, I. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720–1748 (2022).
Balenkov O.Yu., Yuldasheva D.Yu., Kireev G.V., Kamishov S.V. Study of cancer incidence among the population of Tashkent // Journal of Theoretical and Clinical Medicine. –2007. –No. 3. –P. 90-92. [Баленков О.Ю., Юлдашева Д.Ю., Киреев Г.В., Камышов С.В. Изучение онкозаболеваемости населения г.Ташкента // Журнал теоретической и клинической медицины. –2007. –№ 3. –С. 90-92.]
Cartwright R.A., McKinney P.A., O'Brien C. et al. // Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire // Leuk. Res.-2018.- Vol. 12 P.81-88;
Harris N.L., Jaffe E.S., Stein H. et al. // A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group // Blood 2014. Vol. 84. - P. 1361-1392;
Horning S.J.; Weller E.; Kim K. et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin"s lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol. 2014;22(15):3032-8.
James O Armitage How I treat patients with diffuse large B-cell lymphoma. 2017 Jul 1;110(1):29-36.
Kamishov S.V. Methods of extracorporeal immunopharmacotherapy: from general clinical to oncological practice // Bulletin of the National Science. medical surgeon center named after N.I. Pirogov. –2018. –T.13. –No. 3. –P. 126-131. [ Камышов С.В. Методы экстракорпоральной иммунофармакотерапии: от общей клинической - к онкологической практике // Вестник Нац. медико-хирург. центра им. Н.И. Пирогова. –2018. –Т.13. –№ 3. –С. 126-131.]
Kamishov S.V., Tillyashaykhov M.N. Influence of supporting immunotherapy on oxidative processes and antioxidant protection system in cervical cancer patients // Евразийский Союз Ученых. 2019. №3-1 (60).
Kamishov S.V., Tillyashaykhov M.N. The effect of extracorporeal immunopharmacotherapy on intracellular metabolism in cervical cancer patients //Клиническая и экспериментальная онкология. –2019. –№ 4. –P. 11-21.
Kamishov, S.V., Modern immunopharmacotherapy in the complex treatment of cervical cancer. Bulletin of Science and Education. 2018. 2(6), p.42.
Kamyshov, S.V., Yuldasheva, N.S. and Pulatov, D.A., 2013. Supportive immunotherapy in complex treatment of patiens with oncogynaecological diseases. Cancer Immunology Research, 3, pp.158-161.
Miller T.P.; Dahlberg S.; Cassady J.R. et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin"s lymphoma. N Engl J Med. 2018;339(1):21-6.
Shenkier T.N.; Voss N.; Fairey R. et al. Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency. J Clin Oncol. 2022;20(1):197-204.
Swerdlow S, Campo E, Harris N, et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition ed. Lyon, France: IARC; 2017.